Mainstream Bio

Mainstream Bio

主流源生物

Mainstream Bio

Biotech/Healthcare

Mainstream Biosciences is an R&D-focused biotechnology company developing next-generation peptide therapeutics. Using its advanced, differentiated peptide-drug conjugate platform and multifunctional peptide screening and optimization platform, the company has developed a pipeline of peptide drug…

Latest round: Series A (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-11-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.